Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT06211764 |
Title | A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guérin (BCG) (SunRISe-5) |
Acronym | SunRISe-5 |
Recruitment | Recruiting |
Gender | both |
Phase | Phase III |
Variant Requirements | No |
Sponsors | Janssen Research & Development, LLC |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | ROU | POL | ITA | GBR | FRA | ESP | DEU | BRA | BEL | ARG |